BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 21470183)

  • 1. In silico predictions of ADME-Tox properties: drug absorption.
    Geerts T; Vander Heyden Y
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):339-61. PubMed ID: 21470183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico ADME-Tox modeling: progress and prospects.
    Alqahtani S
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets.
    Wenzel J; Matter H; Schmidt F
    J Chem Inf Model; 2019 Mar; 59(3):1253-1268. PubMed ID: 30615828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.
    Larregieu CA; Benet LZ
    AAPS J; 2013 Apr; 15(2):483-97. PubMed ID: 23344793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
    van de Waterbeemd H
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-ADME relationship: still a long way to go?
    Hou T; Wang J
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):759-70. PubMed ID: 18611116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in computational prediction of drug absorption and permeability in drug discovery.
    Hou T; Wang J; Zhang W; Wang W; Xu X
    Curr Med Chem; 2006; 13(22):2653-67. PubMed ID: 17017917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
    Honório KM; Moda TL; Andricopulo AD
    Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. truPK -- human pharmacokinetic models for quantitative ADME prediction.
    Subramanian K
    Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):555-64. PubMed ID: 16863461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for absorption screening in drug discovery and development.
    Bohets H; Annaert P; Mannens G; Van Beijsterveldt L; Anciaux K; Verboven P; Meuldermans W; Lavrijsen K
    Curr Top Med Chem; 2001 Nov; 1(5):367-83. PubMed ID: 11899103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Assessment of ADME Properties: Advances in Caco-2 Cell Monolayer Permeability Modeling.
    Pham-The H; Cabrera-Pérez MÁ; Nam NH; Castillo-Garit JA; Rasulev B; Le-Thi-Thu H; Casañola-Martin GM
    Curr Top Med Chem; 2018; 18(26):2209-2229. PubMed ID: 30499410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets.
    Clark AM; Dole K; Coulon-Spektor A; McNutt A; Grass G; Freundlich JS; Reynolds RC; Ekins S
    J Chem Inf Model; 2015 Jun; 55(6):1231-45. PubMed ID: 25994950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    Talevi A; Goodarzi M; Ortiz EV; Duchowicz PR; Bellera CL; Pesce G; Castro EA; Bruno-Blanch LE
    Eur J Med Chem; 2011 Jan; 46(1):218-28. PubMed ID: 21112128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of HT-ADME in drug discovery.
    Morgan D
    Bioanalysis; 2011 Nov; 3(21):2385-7. PubMed ID: 22074279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical QSAR Analysis of Passive Permeability Across Caco-2 Monolayers.
    Lanevskij K; Didziapetris R
    J Pharm Sci; 2019 Jan; 108(1):78-86. PubMed ID: 30321548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans.
    Klopman G; Stefan LR; Saiakhov RD
    Eur J Pharm Sci; 2002 Dec; 17(4-5):253-63. PubMed ID: 12453615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying machine learning techniques for ADME-Tox prediction: a review.
    Maltarollo VG; Gertrudes JC; Oliveira PR; Honorio KM
    Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):259-71. PubMed ID: 25440524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools.
    Tao L; Zhang P; Qin C; Chen SY; Zhang C; Chen Z; Zhu F; Yang SY; Wei YQ; Chen YZ
    Adv Drug Deliv Rev; 2015 Jun; 86():83-100. PubMed ID: 26037068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery.
    Gobeau N; Stringer R; De Buck S; Tuntland T; Faller B
    Pharm Res; 2016 Sep; 33(9):2126-39. PubMed ID: 27278908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.